Funding for research is a high priority for Hemophilia of Georgia.
Gene Therapy Clinical Trials
Since 2012, Hemophilia of Georgia has funded clinical trial research at two institutions: St. Jude Children's Research Hospital in Memphis, Tennessee and the Aflac Cancer and Blood Disorders Center at Emory University, Atlanta. Our contribution of almost $6 million is for clinical trials to cure hemophilia. The Hemophilia of Georgia funding enables this research to progress more quickly. Additional information about this research is available in this Horizons in Hemophilia newsletter article.
Hemophilia Clinical Scientist Development Grant
Since 2003, Hemophilia of Georgia has funded physician researchers to conduct translational research on bleeding disorders and their complications. Each grant is for $75,000 a year, renewable for up to five years, with an additional $7,500 per year for indirect costs. The grant requires an 80% time commitment to bleeding disorder-related research.
Through this program, Hemophilia of Georgia hopes to help create the next generation of hemostasis researchers. This funding will allow a physician who has completed research training to advance to the status of an independent investigator. Our goal is for the achievements of these scientists to improve the lives of people with bleeding disorders.
Applications are accepted year round. Applicants must have an MD degree and have a minimum of three years of research experience. Because the purpose of this grant program is to further the development of beginning researchers, well-established scientists (including recipients of NIH R01 or NSF grants) are not eligible to apply.
Applicants must be U.S. citizens, have permanent resident status (hold an I-551), or be a non-citizen national. Applicants must be sponsored by a non-federal public or private non-profit institution that conducts health related research within the U.S. and its possessions. A full-time faculty appointment is required throughout the award period.
Questions about the application process can be addressed to Hemophilia of Georgia’s Director of Training, Research & Advocacy, Jeff Cornett, via phone (770-518-8272) or email email@example.com.
Read about the current and past Research Grantees.
Funding for the American Thrombosis and Hemostasis Network
HoG was a catalyst for the creation of the American Thrombosis and Hemostasis Network (ATHN), a non-profit organization founded to advance and improve the care of individuals affected by bleeding and thrombotic disorders. ATHN’s mission is to provide stewardship of a secure national database, adherent to all privacy guidelines, which will be used to support clinical outcomes analysis, research, advocacy and public health reporting in the hemostasis and thrombosis community.
Funding an Active Research Community in Georgia
Hemophilia of Georgia provides funding for research by the Infectious Disease/Hemophilia Program at Emory Midtown and the Hemophilia Treatment Centers at Emory/CHOA and Georgia Regents University. Their research includes not only inherited bleeding disorders but also HIV and Hepatitis C.
Judith Graham Pool Postdoctoral Research Fellowships
Hemophilia of Georgia has been a long-time funder of the JGP Fellowship program of the National Hemophilia Foundation.